Mitochondrion: Main organelle in orchestrating cancer escape from chemotherapy

(2024) Mitochondrion: Main organelle in orchestrating cancer escape from chemotherapy. Cancer Reports. ISSN 25738348 (ISSN)

Full text not available from this repository.

Abstract

Background: Chemoresistance is a challenging barrier to cancer therapy, and in this context, the role of mitochondria is significant. We put emphasis on key biological characteristics of mitochondria, contributing to tumor escape from various therapies, to find the “Achilles' Heel” of cancer cells for future drug design. Recent findings: The mitochondrion is a dynamic organelle, and its existence is important for tumor growth. Its metabolites also cooperate with cell signaling in tumor proliferation and drug resistance. Conclusion: Biological characteristics of this organelle, such as redox balance, DNA depletion, and metabolic reprogramming, provide flexibility to cancer cells to cope with therapy-induced stress. © 2023 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Item Type: Article
Keywords: drug resistance mitochondria neoplasm oxidation–reduction devimistat dordaviprone mitochondrial DNA mitomycin telaglenastat bladder cancer breast cancer cancer cell cancer chemotherapy cancer resistance cell organelle colorectal cancer drug design endometrium cancer glioma homeostasis human metabolic reprogramming mitochondrial biogenesis mitochondrial DNA depletion mitochondrial dynamics mitochondrion oxidation reduction reaction renal cell carcinoma Review signal transduction tumor escape tumor growth
Journal or Publication Title: Cancer Reports
Journal Index: Scopus
Volume: 7
Number: 2
Identification Number: https://doi.org/10.1002/cnr2.1942
ISSN: 25738348 (ISSN)
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/30708

Actions (login required)

View Item View Item